Product Information
GUANFACINE 2 MG TABLET is a generic product labeled by TWi Pharmaceuticals, Inc., priced at $0.2673 per EA under NDC 24979019901. Its NADAC has been published 189 times since Feb 22, 2023.
FDA first approved this application on Jun 8, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
TWi Pharmaceuticals, Inc.NDC
24979019901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUANFACINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216399FDA Approved
6/8/2022
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GUANFACINE 2 MG TABLET has been published 189 times since Feb 22, 2023, and over the history we have for it it has declined 58.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2673 per EA |
|---|---|
| All-time high | $0.6823 (Jul 12, 2023) |
| All-time low | $0.2410 (Feb 18, 2026) |
| 52-week high | $0.3037 |
| 52-week low | $0.2410 |
| Median price | $0.3257 |
| Average price | $0.3950 |
| Largest weekly change | +61.2% (Aug 21, 2024) |
| Weeks tracked | 189 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TWi Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guanfacine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central alpha-2 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GUANFACINE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GUANFACINE 2 MG TABLET, manufactured by TWi Pharmaceuticals, Inc., is $0.2673 per EA (NDC 24979019901), effective Sep 30, 2026.
How has the price of GUANFACINE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for GUANFACINE 2 MG TABLET has declined 58.8%. It has been tracked across 189 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for GUANFACINE 2 MG TABLET?
Since Feb 22, 2023, the NADAC for GUANFACINE 2 MG TABLET has ranged from a low of $0.2410 (Feb 18, 2026) to a high of $0.6823 (Jul 12, 2023), with a median of $0.3257 per EA.
Are there cheaper alternatives to GUANFACINE 2 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GUANFACINE HCL ER 2 MG TABLET, is $0.1477 per EA — about 45% below GUANFACINE 2 MG TABLET.
Who manufactures GUANFACINE 2 MG TABLET?
GUANFACINE 2 MG TABLET (NDC 24979019901) is labeled by TWi Pharmaceuticals, Inc., and CMS classifies it as a generic product.